Insha Ahmad

2.7k total citations · 2 hit papers
12 papers, 1.9k citations indexed

About

Insha Ahmad is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Insha Ahmad has authored 12 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Insha Ahmad's work include RNA and protein synthesis mechanisms (5 papers), Chemical Synthesis and Analysis (4 papers) and CAR-T cell therapy research (2 papers). Insha Ahmad is often cited by papers focused on RNA and protein synthesis mechanisms (5 papers), Chemical Synthesis and Analysis (4 papers) and CAR-T cell therapy research (2 papers). Insha Ahmad collaborates with scholars based in United States, South Korea and Japan. Insha Ahmad's co-authors include Peter G. Schultz, Travis S. Young, Jun Yin, Luke L. Lairson, Douglas D. Young, Costas A. Lyssiotis, Michael J. Bollong, Glen Spraggon, Michael Jahnz and Hwayoung Yun and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Insha Ahmad

12 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Enhanced System for Unnatural Amino Acid Mutagenesis in E. coli

2009 538 citations Travis S. Young, Insha Ahmad et al. Journal of Molecular Biology profile →
A regenerative approach to the treatment of multiple sclerosis

2013 403 citations V. Deshmukh, Virginie Tardif et al. Nature profile →

Peers

Countries citing papers authored by Insha Ahmad

Since Specialization

Citations

This map shows the geographic impact of Insha Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Insha Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Insha Ahmad more than expected).

Fields of papers citing papers by Insha Ahmad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Insha Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Insha Ahmad. The network helps show where Insha Ahmad may publish in the future.

Co-authorship network of co-authors of Insha Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Insha Ahmad. A scholar is included among the top collaborators of Insha Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Insha Ahmad. Insha Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A short ORF-encoded transcriptional regulator 2021 ·Proceedings of the National Academy of Sciences ·Minseob Koh, Insha Ahmad, Yeonjin Ko, Yuxiang Zhang, Thomas F. Martínez, Jolene K. Diedrich, Qian Chu, James J. Moresco, Michael A. Erb, Alan Saghatelian, Peter G. Schultz, Michael J. Bollong	38
2	Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs 2018 ·Bioconjugate Chemistry ·Avinash Muppidi, Sang Jun Lee, Che‐Hsiung Hsu, Huafei Zou, (unknown), (unknown), (unknown), Pengyu Yang, Elizabeth Chao, Insha Ahmad, Andreas Crameri, Danling Wang, Ashley Woods, Weijun Shen	20
3	A metabolite-derived protein modification integrates glycolysis with KEAP1–NRF2 signalling 2018 ·Nature ·Michael J. Bollong, Gihoon Lee, John S. Coukos, Hwayoung Yun, Claudio Zambaldo, Jae Won Chang, Emily N. Chin, Insha Ahmad, Arnab K. Chatterjee, Luke L. Lairson, Peter G. Schultz, Raymond E. Moellering	264
4	A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers 2017 ·Proceedings of the National Academy of Sciences ·Michael J. Bollong, Mika Pietilä, (unknown), Tapasree Roy Sarkar, Insha Ahmad, Rama Soundararajan, Costas A. Lyssiotis, Sendurai A. Mani, Peter G. Schultz, Luke L. Lairson	57
5	Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer 2016 ·Angewandte Chemie International Edition ·Yu Cao, David T. Rodgers, Juanjuan Du, Insha Ahmad, Eric Hampton, S. Y. Jennifer, Magdalena Mazagova, Seihyun Choi, Hwayoung Yun, Han Xiao, Pengyu Yang, Xiaozhou Luo, Reyna K. V. Lim, Holly Pugh, Feng Wang, Stephanie A. Kazane, Timothy M. Wright, Chan Hyuk Kim, Peter G. Schultz, Travis S. Young	103
6	Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer 2016 ·Angewandte Chemie ·Yu Cao, David T. Rodgers, Juanjuan Du, Insha Ahmad, Eric Hampton, S. Y. Jennifer, Magdalena Mazagova, Seihyun Choi, Hwayoung Yun, Han Xiao, Pengyu Yang, Xiaozhou Luo, Reyna K. V. Lim, Holly Pugh, Feng Wang, Stephanie A. Kazane, Timothy M. Wright, Chan Hyuk Kim, Peter G. Schultz, Travis S. Young	8
7	Reshaping Antibody Diversity 2013 ·Cell ·Feng Wang, Damian C. Ekiert, Insha Ahmad, Wenli Yu, Yong Zhang, Omar A. Bazirgan, Ali Torkamani, Terje Raudsepp, Waithaka Mwangi, Michael F. Criscitiello, Ian A. Wilson, Peter G. Schultz, Vaughn V. Smider	177
8	A regenerative approach to the treatment of multiple sclerosis breakdown → 2013 ·Nature ·V. Deshmukh, Virginie Tardif, Costas A. Lyssiotis, (unknown), Bilal E. Kerman, Hyung Joon Kim, Krishnan Padmanabhan, Jonathan G. Swoboda, Insha Ahmad, Tôru Kondo, Fred H. Gage, Argyrios N. Theofilopoulos, Brian R. Lawson, Peter G. Schultz, Luke L. Lairson	403
9	Evolution of cyclic peptide protease inhibitors 2011 ·Proceedings of the National Academy of Sciences ·Travis S. Young, Douglas D. Young, Insha Ahmad, John M. Louis, Stephen J. Benkovic, Peter G. Schultz	112
10	An Evolved Aminoacyl-tRNA Synthetase with Atypical Polysubstrate Specificity, 2011 ·Biochemistry ·Douglas D. Young, Travis S. Young, Michael Jahnz, Insha Ahmad, Glen Spraggon, Peter G. Schultz	182
11	An Enhanced System for Unnatural Amino Acid Mutagenesis in E. coli breakdown → 2009 ·Journal of Molecular Biology ·Travis S. Young, Insha Ahmad, Jun Yin, Peter G. Schultz	538
12	Expanding the Genetic Repertoire of the Methylotrophic Yeast Pichia pastoris 2009 ·Biochemistry ·Travis S. Young, Insha Ahmad, Ansgar Brock, Peter G. Schultz	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact